Published in Pediatr Diabetes on March 08, 2013
Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med (2014) 3.38
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol (2016) 1.59
Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab (2014) 1.29
Frequency of morning ketosis after overnight insulin suspension using an automated nocturnal predictive low glucose suspend system. Diabetes Care (2014) 1.17
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial. Diabetes Care (2016) 1.03
Challenges and future directions of the T1D Exchange Clinic Network and registry. J Diabetes Sci Technol (2013) 0.92
Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Curr Opin Endocrinol Diabetes Obes (2015) 0.88
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes. Diabetes Care (2015) 0.85
Understanding the construct of fear of hypoglycemia in pediatric type 1 diabetes. J Pediatr Psychol (2014) 0.84
Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon. J Diabetes Sci Technol (2014) 0.84
Low socioeconomic status is associated with adverse events in children and teens on insulin pumps under a universal access program: a population-based cohort study. BMJ Open Diabetes Res Care (2016) 0.79
Clinical presentation and memory function in youth with type 1 diabetes. Pediatr Diabetes (2015) 0.79
In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes. Pediatr Diabetes (2016) 0.79
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet (2016) 0.78
Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery. J Diabetes Sci Technol (2015) 0.77
Moving the Journey Towards Independence: Adolescents Transitioning to Successful Diabetes Self-Management. J Pediatr Nurs (2015) 0.77
Type 1 diabetes: addressing the transition from pediatric to adult-oriented health care. Res Rep Endocr Disord (2016) 0.75
Hypoglycemia induced by insulin as a triggering factor of cognitive deficit in diabetic children. ScientificWorldJournal (2014) 0.75
Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study. Pediatr Diabetes (2016) 0.75
Technology to Reduce Hypoglycemia. J Diabetes Sci Technol (2015) 0.75
Reduction of hypoglycaemic events with a behavioural intervention: a randomized clinical trial for paediatric patients with Type 1 diabetes mellitus. Diabet Med (2015) 0.75
Altered Integration of Structural Covariance Networks in Young Children With Type 1 Diabetes. Hum Brain Mapp (2016) 0.75
20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes. PLoS One (2016) 0.75
Change in hemoglobin A1c one year following the 2014 American Diabetes Association guideline update. Diabetes Res Clin Pract (2017) 0.75
Design and baseline data from a PCORI-funded randomized controlled trial of family-centered tailoring of diabetes self-management resources. Contemp Clin Trials (2017) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19
The T1D Exchange clinic registry. J Clin Endocrinol Metab (2012) 3.45
Predictors of acute complications in children with type 1 diabetes. JAMA (2002) 3.04
Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care (2007) 2.96
Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care (2009) 2.66
The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care (2004) 2.11
Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes. Diabetes Care (2009) 2.01
The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care (2006) 1.95
Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes. Pediatr Diabetes (2007) 1.38
STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. Diabetes Technol Ther (2010) 1.23
Predictors of diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicentre database. Pediatr Diabetes (2011) 1.21
Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes Care (2012) 1.04
Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009. Diabetes Care (2011) 1.00
A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes (2008) 0.96
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19
Obesity and the metabolic syndrome in children and adolescents. N Engl J Med (2004) 13.99
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med (2002) 11.32
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med (2010) 8.69
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care (2008) 6.53
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet (2010) 6.50
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79
A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol (2003) 5.27
The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care (2009) 4.93
A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology (2003) 4.88
Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol (2005) 4.38
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA (2007) 4.09
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood (2002) 3.93
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology (2007) 3.49
A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology (2004) 3.48
The T1D Exchange clinic registry. J Clin Endocrinol Metab (2012) 3.45
Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol (2005) 3.42
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ (2011) 3.36
Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet (2003) 3.31
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol (2007) 3.18
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol (2003) 3.13
The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care (2007) 3.11
Continuous glucose monitoring in children with type 1 diabetes. J Pediatr (2007) 3.06
Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med (2011) 2.98
Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology (2006) 2.89
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care (2009) 2.85
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther (2013) 2.85
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol (2009) 2.84
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care (2014) 2.83
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83
Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care (2015) 2.79
Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care (2013) 2.73
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology (2012) 2.68
Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes (2005) 2.64
Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab (2004) 2.61
A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care (2005) 2.59
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology (2007) 2.58
A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology (2006) 2.51
Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatr Diabetes (2008) 2.41
Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab (2006) 2.34
Retinal nerve fiber layer thickness in amblyopic eyes. Am J Ophthalmol (2009) 2.29
A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol (2008) 2.26
A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care (2011) 2.26
A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care (2004) 2.20
The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology (2008) 2.19
Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care (2002) 2.15
Randomized trial of infusion set function: steel versus teflon. Diabetes Technol Ther (2013) 2.15
Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract (2011) 2.12
Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics (2011) 2.09
Predictors of changes in glucose tolerance status in obese youth. Diabetes Care (2005) 2.08
Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care (2013) 2.03
Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care (2006) 2.02
Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes. Diabetes Care (2009) 2.01
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol (2004) 2.01
Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. Pediatr Diabetes (2008) 1.98
Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care (2007) 1.98
The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care (2006) 1.95
Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology (2008) 1.94
Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab (2013) 1.92
Measuring insulin resistance: a task worth doing. But how? Pediatr Diabetes (2003) 1.91
Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. J Pediatr (2006) 1.90
Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther (2006) 1.89
Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials. J AAPOS (2009) 1.89
FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group. Diabetes Care (2007) 1.89
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol (2008) 1.87
Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes (2006) 1.86
Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. Cancer Cell (2002) 1.80
Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol (2008) 1.80
Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes (2013) 1.78
Clinical profile and early surgical complications in the Cornea Donor Study. Cornea (2006) 1.77
Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old. Am J Ophthalmol (2003) 1.76